Intérêt des bêtabloquants dans la coronaropathie : mythe ou réalité ? (notice n° 749531)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02217cam a2200289 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123093940.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sorbets, Emmanuel |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Intérêt des bêtabloquants dans la coronaropathie : mythe ou réalité ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 29 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméLes bêtabloquants font partie de l’ordonnance classique du patient coronarien, comme les antiagrégants plaquettaires ou les statines. Pourtant, s’il existe des preuves nombreuses et formelles du bénéfice pronostique en prévention secondaire des antiagrégants et des statines, ce n’est pas le cas pour les bêtabloquants.L’objectif ici est de resituer l’action des bêtabloquants dans la physiopathologie de l’athérome coronaire et de ses complications, et de refaire un point sur les données factuelles de la littérature et des dernières recommandations de la Société Européenne de Cardiologie, afin de remettre à jour et adapter la place des bêtabloquants dans la prise en charge quotidienne de nos patients coronariens. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Betablockers are part of the classic prescription of the coronary patient, like antiplatelet agents or statins. However, if there is numerous and formal evidence of the prognostic benefit in secondary prevention of antiaggregants and statins, this is not the case for beta-blockers.The objective here is to re-situate the action of beta-blockers in the pathophysiology of coronary atheroma and its complications, and to review the factual data in the literature and the latest recommendations of the European Cardiology Society, in order to update and adapt the place of beta-blockers in the daily care of our coronary patients. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | coronaropathie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bêtabloquants |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pronostic |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | angor stable |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | infarctus du myocarde |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prognosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | betablockers |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | myocardial infarction |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | stable angina |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | coronary artery disease |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine | 16 | 3 | 2020-03-01 | p. 110-115 | 1777-2044 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-medecine-2020-3-page-110?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-medecine-2020-3-page-110?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux